Dr. Omar Marar, M.D., a distinguished colon and rectal surgeon and esteemed educator at Central Michigan University Health in Saginaw, Michigan, has witnessed firsthand how early-onset colorectal cancer (EOCRC) is reshaping the surgical landscape. Once considered a disease of older adults, colorectal cancer is increasingly being diagnosed in patients under the age of 50.
This demographic shift challenges established surgical protocols and demands a more individualized approach that balances long-term outcomes, quality of life, and precision-based medicine.
The complexity of surgical decision-making in early-onset cases stems from biology and staging as well as from the psychosocial and genetic dimensions that distinguish younger patients from their older counterparts. Surgeons must navigate a matrix of tumor behavior, genetic predispositions, fertility concerns, and long-term survivorship, often within tight windows of therapeutic opportunity.
Understanding the Rising Incidence of Early-Onset Colorectal Cancer
Over the past two decades, the incidence of colorectal cancer among adults under 50 has risen by more than 50%. Researchers point to a multifactorial cause that includes diet, microbiome imbalance, sedentary behavior, and potential environmental triggers. Yet, what makes EOCRC particularly troubling is its tendency to present at more advanced stages, with aggressive histologic features and a higher likelihood of microsatellite instability (MSI) or hereditary syndromes like Lynch syndrome and familial adenomatous polyposis (FAP).
These distinctions make early detection and individualized surgical planning paramount. Whereas older patients may have slower-growing, localized lesions, younger patients often present with tumors that require rapid, multidisciplinary coordination. This dynamic emphasizes the surgeon’s evolving role as a technical expert and perhaps more importantly as a central strategist in oncologic care.
Surgical intervention remains key to curative intent in colorectal cancer. However, the question of how extensive surgery should be is particularly nuanced in early-onset cases. Standard oncologic principles still apply, but surgeons increasingly weigh these against functional preservation and long-term morbidity.
“Each surgical decision must account for tumor eradication but also for how that decision shapes the patient’s next fifty years,” says Dr. Omar Marar. “Younger patients live longer with the consequences of surgery. Bowel habits, fertility, and emotional recovery are part of the same equation as survival.”
For rectal cancers, minimally invasive approaches such as laparoscopic or robotic-assisted low anterior resection (LAR) and transanal total mesorectal excision (taTME) have become preferred techniques when oncologically appropriate. These methods minimize incision trauma, reduce recovery time, and improve visualization in confined pelvic spaces, all critical for preserving nerves, continence, and sexual function.
In contrast, for left-sided colon cancers or high rectal lesions, segmental resections may suffice, provided clear margins and adequate nodal harvest are achieved. Yet, in genetically predisposed individuals, subtotal colectomy or proctocolectomy may be indicated to mitigate future malignancy risk. The challenge lies in knowing when to favor organ preservation and when to pursue a more radical, prophylactic approach.
Integrating Genetics into Surgical Strategy
One of the most transformative developments in colorectal oncology is the integration of genetic testing into surgical decision-making. Roughly 20% of early-onset cases have a hereditary component, with germline mutations influencing treatment response but also the scope of surgery.
Notes Dr. Marar, “Genetic data can, and should, alter our surgical plans. For instance, if we identify Lynch syndrome, removing only the affected segment may expose the patient to recurrence in another part of the colon. In those cases, a more extensive resection may prevent a second primary cancer.”
Such insights point to the need for preoperative genetic counseling and testing for all EOCRC patients, especially those under 45. A patient-centered approach demands that surgeons discuss the implications of broader resections, long-term surveillance, and familial testing. The collaboration between surgical, medical, and genetic specialists forms the backbone of modern colorectal cancer care, ensuring that intervention aligns with both risk reduction and life goals.
The Role of Minimally Invasive and Organ-Preserving Techniques
Minimally invasive colorectal surgery techniques (MIS) continue to transform colorectal oncology, offering young patients faster recovery, less pain, and fewer postoperative complications. Laparoscopic colectomy and robotic-assisted approaches have proven oncologic equivalence to open surgery while improving visualization in confined anatomical areas.
Rectal cancer, in particular, benefits from taTME and local excision techniques that can preserve sphincter function in select cases. Advances in intraoperative imaging, fluorescence angiography, and nerve-sparing dissection have further refined precision and safety. For patients, the promise of organ preservation, when oncologically safe, represents a life-altering improvement in quality of life.
Still, Dr. Marar cautions that technology is only as good as the judgment behind it. Minimally invasive does not mean minimal in intent. Each tool must serve the principles of complete resection and patient safety.
This measured approach reflects the broader trend toward tailored therapy, preserving anatomy when feasible, extending resection when prudent, and integrating MIS only where it strengthens oncologic outcomes.
Because EOCRC affects patients often in their 30s and 40s, fertility preservation and postoperative function weigh heavily in surgical planning. Preoperative consultation with reproductive specialists is essential, particularly for women undergoing pelvic radiation or total mesorectal excision. Men may also face risks to fertility and sexual function from nerve injury or chemotherapy-induced gonadotoxicity.
Bowel function is another vital consideration. Procedures like low anterior resection syndrome (LARS) can significantly affect quality of life. Prehabilitation, dietary modification, and pelvic floor rehabilitation are emerging adjuncts to improve long-term outcomes.
“Success in colorectal surgery is not just measured by tumor-free margins. It’s measured by how well a patient returns to their life, their relationships, and their goals. We owe them survivorship that feels whole,” says Dr. Marar.
Such sentiments reinforce the holistic view that younger cancer patients now demand, an approach that values psychological support and life planning as much as technical excellence.
Multidisciplinary Collaboration: A Cornerstone of EOCRC Management
In early-onset cases, multidisciplinary tumor boards have become indispensable. Surgeons work closely with medical oncologists, radiation oncologists, gastroenterologists, geneticists, and psychologists to ensure decisions are coordinated and evidence-based. For locally advanced rectal cancer, for example, total neoadjuvant therapy (TNT) has redefined resectability and improved pathological response rates.
This team-based approach ensures that patients receive personalized care sequences, sometimes even deferring surgery in cases of complete clinical response under strict surveillance protocols. These “watch-and-wait” strategies highlight the growing shift from purely surgical intervention toward integrated, adaptive management models.
Long-term follow-up is essential for EOCRC patients, who face higher risks of recurrence or secondary malignancy. Surveillance protocols must balance vigilance with practicality, combining periodic colonoscopy, imaging, and circulating tumor DNA (ctDNA) monitoring.
Equally important is addressing survivorship holistically. Nutritional counseling, psychosocial support, and lifestyle modification programs form integral components of modern postoperative care.
Younger survivors often experience the dual challenge of returning to careers and family life while managing the emotional aftermath of cancer. The surgeon’s role does not end in the operating room but instead extends into education, encouragement, and lifelong partnership in health.
Surgical decision-making in early-onset colorectal cancer intersects precision medicine, human empathy, and evolving science. The modern colorectal surgeon is both technician and advocate, blending anatomical mastery with long-range foresight. For young patients, every decision carries amplified meaning, and true excellence in colorectal surgery lies in balancing cure with compassion, and innovation with integrity.
About Dr. Omar Marar
Dr. Omar Marar, is a distinguished colon and rectal surgeon and educator. He previously served as an assistant professor at Central Michigan University Health in Saginaw, Michigan, where he was recognized for his clinical excellence and commitment to medical education, including receiving the 2021 Dr. Debasish and Chinu Mridha Spirit of Teaching Award.
Dr. Marar has transitioned to a leadership role within a new healthcare initiative. He is currently a key member of Valley Multi Specialty, a new medical group launched by Valley Surgical Clinics. His practice continues to focus on advanced surgical interventions, including robotic-assisted and minimally invasive techniques, while emphasizing a holistic, patient-centered approach to survivorship and oncologic care.
